Accepted Manuscript Title: Saponins: Anti-diabetic principles from medicinal plants-A review Author: Elekofehinti Olusola Olalekan PII: DOI: Reference:

S0928-4680(15)00019-X http://dx.doi.org/doi:10.1016/j.pathophys.2015.02.001 PATPHY 832

To appear in:

Pathophysiology

Received date: Revised date: Accepted date:

5-12-2013 25-1-2015 9-2-2015

Please cite this article as: E.O. Olalekan, Saponins: Anti-diabetic principles from medicinal plants-A review, Pathophysiology (2015), http://dx.doi.org/10.1016/j.pathophys.2015.02.001 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

1

Saponins: Anti-diabetic principles from medicinal plants-A review

2

Elekofehinti Olusola Olalekan

4

Department of Biochemistry, Adekunle Ajasin University, Akungba, Akoko, Ondo State.

5

Nigeria.

cr

ip t

3

6

us

7

*Corresponding Author:

9

Elekofehinti Olusola Olalekan

10

Department of Biochemistry,

11

Adekunle Ajasin University Akungba Akoko.

12

P.M.B 001 Akungba Akoko. Ondo State. Nigeria

13

e-mail: [email protected], [email protected]

14

TEL: +2348034450611

16 17 18 19

M

d

te

Ac ce p

15

an

8

20 21 22 23 24 1 Page 1 of 32

Abstract

26

Diabetes mellitus (DM) represents a global health problem. It is the most common of the

27

endocrine disorders and is characterized by chronic hyperglycemia due to relative or absolute

28

lack of insulin secretion or insulin actions. According to the World Health Organization

29

projections, the diabetes population is likely to increase to 300 million or more by the year 2025.

30

Current synthetic agents and insulin used effectively for the treatment of diabetes are scarce

31

especially in rural areas, expensive and have prominent adverse effects. Complementary and

32

alternative approaches to diabetes management such as isolation of phytochemicals with anti-

33

hyperglycemic activities from medicinal plants is therefore imperative. Saponins are

34

phytochemical with structural diversity and biological activities. This paper reviews saponins

35

and various plants from which they were isolated as well as properties that make them ideal for

36

antidiabetic remedy.

39 40 41 42 43 44

cr

us

an

M

d te

38

Keyword: Diabetes, Medicinal Plants, Saponin, Hyperglyceamia, Phytochemicals.

Ac ce p

37

ip t

25

45 46 47 48 2 Page 2 of 32

Introduction

50

Diabetes mellitus (DM), a common and prevalent disease, is a metabolic disorder affecting the

51

citizens of both developed and developing countries [1]. It is one of the five leading causes of

52

death in the world. It is projected that about 300 million people will have the disease by the year

53

2025 [2-3]. Diabetes is divided into two major categories: Type 1 also known as Insulin-

54

dependent diabetes mellitus (IDDM) and type 2 known as non- insulin dependent diabetes

55

mellitus (NIDDM). Type 1 (IDDM) is an autoimmune disorder caused by auto aggressive T-

56

lymphocytes that infiltrate the pancreas and destroy insulin producing β-cells leading to

57

hypoinsulinaemia and thus hyperglycemic condition [4-5]. This develops over a period of time to

58

diabetic complications such as nephropathy, retinopathy, neuropathy, and cardiomyopathy [5,6].

59

Associated metabolic complications of type-I diabetes are due to insulin deficiency and related

60

glucose under-utilization of the insulin-dependent tissue, such as liver, and glucose over-

61

utilization in insulin-independent tissue, such as kidney [5,7]. Type 2 diabetes (NIDDM) is

62

known to have a strong genetic component with contributing environmental determinants.

63

Though the disease is genetically heterogeneous, there appears to be a fairly consistent

64

phenotype once the disease is fully manifested [8]. Whatever the pathogenic causes, the early

65

stage of type 2 diabetes is characterized by insulin resistance in insulin-targeting tissues, mainly

66

the liver, skeletal muscle, and adipocytes. Insulin resistance in these tissues is associated with

67

excessive glucose production by the liver and impaired glucose utilization by peripheral tissues

68

[9-10].

Ac ce p

te

d

M

an

us

cr

ip t

49

69 70

3 Page 3 of 32

Type 2 diabetes can also be influenced by ethnicity, degree of obesity, distribution of body fat,

72

sedentary lifestyle, aging, and other concomitant medical conditions [8,11]. Treatment of DM

73

takes three main forms: (i) diet and exercise, (ii) insulin replacement therapy and (iii) the

74

use of oral hypoglycemic agents (sulfonylureas and biguanides) [12].

75

Although, considerable progress in the treatment of diabetes by oral hypoglycemic agent has

76

been made, search for newer drugs continues due to the limitation of existing synthetic drugs

77

such as hypoglycemia, drug-resistance, dropsy, and weight gain [13]. Thus, there is still a

78

challenge in the management of diabetes without any side effects. Reports have shown that about

79

80% of the world population is almost entirely dependent on traditional medicines [14-15]. The

80

ethnobotanical details, antidiabetic and hypoglycemic potential of several plants have been

81

reported [16-18]. Several reports have revealed that the hypoglycaemic activity of most

82

antidiabetic medicinal plants has been attributed to the presence of saponins [19-27]. The

83

evaluation of saponin constituents of medicinal plants seems to be a logical way of

84

searching for new drugs to treat this disease.

85

Saponins are naturally occurring surface-active glycosides. They are mainly produced by plants,

86

but also by lower marine animals and some bacteria [28-29]. Saponins consist of a sugar moiety

87

usually containing glucose, galactose, glucuronic acid, xylose, rhamnose or methylpentose,

88

glycosidically linked to a hydrophobic aglycone (sapogenin) which may be triterpenoid or

89

steroid in nature [30]. The complex structure of saponin is due (a) to the variation in structure of

90

the aglycone, (b) the nature of the side chains and (c) the position of attachment of these moieties

91

on the aglycone [30]. Saponin has been reported to have many pharmacological properties.

Ac ce p

te

d

M

an

us

cr

ip t

71

4 Page 4 of 32

The aim of this review is to collate some available data on saponin isolated from medicinal plant

93

as the phytochemical in plants with antidiabetic effect. It is hoped that the information collated

94

here will provide the reader with information regarding the antidiabetic potential of saponins and

95

stimulate further research into these compounds.

ip t

92

cr

96

2.0

Saponins with antidiabetic properties

98

2.1

Anabasis articulate saponin

99

Saponin from areal parts of A. articulate showed potent glycemic control and prevent metabolic

100

disorders and liver damage caused by hyperglycemia in streptozotocin-induced diabetic

101

hepatopathy in rats. The antihyperglycemic activity was attributed to the ability of saponin to

102

induce the release of insulin from the pancreas [31].

103

2.2

104

Astragalus saponin I , extracted from the root of Astragalus membranaceus (Table 1) has been

105

reported to have various biological activities like increase in the secretion of insulin and C-

106

peptide on rats [32]. Therapeutic effects on several pharmacological targets, such as oxidative

107

stress, advanced glycation end products (AGEs), transforming growth factorβ1 (TGFβ1), in the

108

development of diabetic nephropathy (DN) and is a potential drug for prevention of early DN

109

[33-34]. Astragaloside IV is a glycoside of cycloartane-type triterpene saponin isolated from the

110

Astragalus membranaceus, This saponin has been shown to possess many pharmacological

111

activities including antidiabetes [34]. It also showed protective effect against the progression of

112

peripheral neuropathy in STZ-induced diabetic rats [35]. The antidiabetic mechanism of this

d

M

an

us

97

Ac ce p

te

Astragalus membranaceus saponin

5 Page 5 of 32

compound is through a decrease in blood glucose concentration and an increase in plasma insulin

114

levels [35]. In another study, Astragaloside IV at 25 and 50 mg/kg was reported to significantly

115

decrease blood glucose, triglyceride and insulin levels, and inhibited the mRNA and protein

116

expression as well as enzyme activity of glycogen phosphorylase and glucose 6 phsphatase in

117

diabetic mice [36].

118

2.3

119

A 1%

120

male diabetic rats for three weeks significantly decreased plasma glucose and reduced the

121

activity of glucose 6 phosphatase in the liver [37].

122

2.4

123

Diosgenin [25R-spriost-5-en-3β-ol] is a hydrolysate of dioscin contained in the rootstock of yam.

124

It is a steroidal saponin, with many biological activities. Consumption of diosgenin demonstrated

125

that it possessed hypoglycemic effect. One property of this saponin that is beneficial in diabetes

126

is reduction of intestinal disaccharidase activities. Saponin from yam reduced intestinal sucrase

127

activity in experimental studies in diabetic male wistar rats. The activity of glucose -6- phosphate

128

was also significantly increased [38-39].

129

2.5

130

Saponin is very abundant in the seed of Entada phaseoloides. Saponin from the seed of E.

131

phaseoloides significantly reduced fasted blood glucose, serum insulin levels and alleviates

132

hyperglycemia associated oxidative stress in type 2 DM rats. Also, a significantly

133

hypolipidemic effect and an improvement in tissue steatosis was observed after saponin

cr

ip t

113

us

Dioscorea polygonoides saponin

Ac ce p

te

d

M

Dioscorea rotundata (Yam) saponin

an

inclusion of steroidal saponin (Table 1) from Dioscorea polygonoides in the diet of

Entada phaseoloides saponin

6 Page 6 of 32

administration. The observed effect of saponin implied that it exhibit its hypoglycemic effect

135

through improving peripheral insulin resistance rather than protecting pancreas islet β-cells

136

and stimulating insulin secretion [40].

137

2.6.

138

Garcinia kola is a species of flowering plant in the Clusiaceae or Guttiferae family. Its natural

139

habitat is subtropical or tropical moist lowland forests [41]. It has been proved to be one of the

140

many non-timber forest products that are of high socio-economic importance(Adebisi, 2004).

141

The findings of [42] indicated that administration of saponin from G. kola in alloxan-induced

142

diabetic rats caused a significant (P

Saponins: Anti-diabetic principles from medicinal plants - A review.

Diabetes mellitus (DM) represents a global health problem. It is the most common of the endocrine disorders and is characterized by chronic hyperglyce...
327KB Sizes 26 Downloads 22 Views